Review



af1997 mouse anti nobox  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems af1997 mouse anti nobox
    Af1997 Mouse Anti Nobox, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 465 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/af1997 mouse anti nobox/product/R&D Systems
    Average 95 stars, based on 465 article reviews
    af1997 mouse anti nobox - by Bioz Stars, 2026-03
    95/100 stars

    Images



    Similar Products

    92
    Novus Biologicals nbp2 46193 mouse anti p63 tp63
    Nbp2 46193 Mouse Anti P63 Tp63, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nbp2 46193 mouse anti p63 tp63/product/Novus Biologicals
    Average 92 stars, based on 1 article reviews
    nbp2 46193 mouse anti p63 tp63 - by Bioz Stars, 2026-03
    92/100 stars
      Buy from Supplier

    95
    R&D Systems af1997 mouse anti nobox
    Af1997 Mouse Anti Nobox, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/af1997 mouse anti nobox/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    af1997 mouse anti nobox - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    90
    Biotechnology Information cdna sequences of foxo1, jun, nobox, bcl-6, sp1
    Cdna Sequences Of Foxo1, Jun, Nobox, Bcl 6, Sp1, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cdna sequences of foxo1, jun, nobox, bcl-6, sp1/product/Biotechnology Information
    Average 90 stars, based on 1 article reviews
    cdna sequences of foxo1, jun, nobox, bcl-6, sp1 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Millipore nobox
    Resveratrol-βcd can inhibit the progression of POI in a mouse model. (A) Schematic diagram of resveratrol-βcd treatment; (B) Changes in body weight of the control group, negative control group (resveratrol-βcd alone), POI model group, and treatment group (POI + resveratrol-βcd) during the treatment, n = 5; (C) On the 20 day after treatment began, the ovaries of the mice were isolated and weighed (D) , with each point representing the weight of one ovary, n = 8; (E) Typical images of follicles at different stages in the ovaries, scale bar = 500 μm and the corresponding statistical analysis results (F) , n = 5; (G) Typical western blot result <t>of</t> <t>LHX8</t> and <t>NOBOX</t> expression levels in ovarian tissue, n = 3, see the other two western blot replicates in Supplementary Fig. ; All the repetitive results of western blot in this paper can be found in Supplementary Fig. , which will not be described afterwards; (H) Total RNA was extracted from ovarian tissue, and qPCR was used to analyze the transcriptional changes of Ddx4 and Pou5f1 , n = 5; (I) On day 20 post treatment, mouse serum was collected to detect AMH, FSH and E2 (J) levels in the blood, n = 5. (K) Estrous cycles examination by vaginal smears, scale bar = 200 μm, percentage of time on cycle phase was shown on the right, M/D = Metestrus and Diestrus, n = 10; (L) Reproductive activity analysis of different treatment group, n = 15; Statistical analysis was performed using two-way ANOVA (B) , and one-way ANOVA ( D,F,H,I,J and K ) comparison was made POI vs. control, POI vs. resveratrol-βcd and POI vs. POI + resveratrol-βcd; ns, not significant
    Nobox, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nobox/product/Millipore
    Average 90 stars, based on 1 article reviews
    nobox - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology mouse anti nobox
    Resveratrol-βcd can inhibit the progression of POI in a mouse model. (A) Schematic diagram of resveratrol-βcd treatment; (B) Changes in body weight of the control group, negative control group (resveratrol-βcd alone), POI model group, and treatment group (POI + resveratrol-βcd) during the treatment, n = 5; (C) On the 20 day after treatment began, the ovaries of the mice were isolated and weighed (D) , with each point representing the weight of one ovary, n = 8; (E) Typical images of follicles at different stages in the ovaries, scale bar = 500 μm and the corresponding statistical analysis results (F) , n = 5; (G) Typical western blot result <t>of</t> <t>LHX8</t> and <t>NOBOX</t> expression levels in ovarian tissue, n = 3, see the other two western blot replicates in Supplementary Fig. ; All the repetitive results of western blot in this paper can be found in Supplementary Fig. , which will not be described afterwards; (H) Total RNA was extracted from ovarian tissue, and qPCR was used to analyze the transcriptional changes of Ddx4 and Pou5f1 , n = 5; (I) On day 20 post treatment, mouse serum was collected to detect AMH, FSH and E2 (J) levels in the blood, n = 5. (K) Estrous cycles examination by vaginal smears, scale bar = 200 μm, percentage of time on cycle phase was shown on the right, M/D = Metestrus and Diestrus, n = 10; (L) Reproductive activity analysis of different treatment group, n = 15; Statistical analysis was performed using two-way ANOVA (B) , and one-way ANOVA ( D,F,H,I,J and K ) comparison was made POI vs. control, POI vs. resveratrol-βcd and POI vs. POI + resveratrol-βcd; ns, not significant
    Mouse Anti Nobox, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti nobox/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    mouse anti nobox - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology nobox ihc wb
    Resveratrol-βcd can inhibit the progression of POI in a mouse model. (A) Schematic diagram of resveratrol-βcd treatment; (B) Changes in body weight of the control group, negative control group (resveratrol-βcd alone), POI model group, and treatment group (POI + resveratrol-βcd) during the treatment, n = 5; (C) On the 20 day after treatment began, the ovaries of the mice were isolated and weighed (D) , with each point representing the weight of one ovary, n = 8; (E) Typical images of follicles at different stages in the ovaries, scale bar = 500 μm and the corresponding statistical analysis results (F) , n = 5; (G) Typical western blot result <t>of</t> <t>LHX8</t> and <t>NOBOX</t> expression levels in ovarian tissue, n = 3, see the other two western blot replicates in Supplementary Fig. ; All the repetitive results of western blot in this paper can be found in Supplementary Fig. , which will not be described afterwards; (H) Total RNA was extracted from ovarian tissue, and qPCR was used to analyze the transcriptional changes of Ddx4 and Pou5f1 , n = 5; (I) On day 20 post treatment, mouse serum was collected to detect AMH, FSH and E2 (J) levels in the blood, n = 5. (K) Estrous cycles examination by vaginal smears, scale bar = 200 μm, percentage of time on cycle phase was shown on the right, M/D = Metestrus and Diestrus, n = 10; (L) Reproductive activity analysis of different treatment group, n = 15; Statistical analysis was performed using two-way ANOVA (B) , and one-way ANOVA ( D,F,H,I,J and K ) comparison was made POI vs. control, POI vs. resveratrol-βcd and POI vs. POI + resveratrol-βcd; ns, not significant
    Nobox Ihc Wb, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nobox ihc wb/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    nobox ihc wb - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology anti nobox
    Resveratrol-βcd can inhibit the progression of POI in a mouse model. (A) Schematic diagram of resveratrol-βcd treatment; (B) Changes in body weight of the control group, negative control group (resveratrol-βcd alone), POI model group, and treatment group (POI + resveratrol-βcd) during the treatment, n = 5; (C) On the 20 day after treatment began, the ovaries of the mice were isolated and weighed (D) , with each point representing the weight of one ovary, n = 8; (E) Typical images of follicles at different stages in the ovaries, scale bar = 500 μm and the corresponding statistical analysis results (F) , n = 5; (G) Typical western blot result <t>of</t> <t>LHX8</t> and <t>NOBOX</t> expression levels in ovarian tissue, n = 3, see the other two western blot replicates in Supplementary Fig. ; All the repetitive results of western blot in this paper can be found in Supplementary Fig. , which will not be described afterwards; (H) Total RNA was extracted from ovarian tissue, and qPCR was used to analyze the transcriptional changes of Ddx4 and Pou5f1 , n = 5; (I) On day 20 post treatment, mouse serum was collected to detect AMH, FSH and E2 (J) levels in the blood, n = 5. (K) Estrous cycles examination by vaginal smears, scale bar = 200 μm, percentage of time on cycle phase was shown on the right, M/D = Metestrus and Diestrus, n = 10; (L) Reproductive activity analysis of different treatment group, n = 15; Statistical analysis was performed using two-way ANOVA (B) , and one-way ANOVA ( D,F,H,I,J and K ) comparison was made POI vs. control, POI vs. resveratrol-βcd and POI vs. POI + resveratrol-βcd; ns, not significant
    Anti Nobox, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti nobox/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    anti nobox - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology anti nobox antibody
    Resveratrol-βcd can inhibit the progression of POI in a mouse model. (A) Schematic diagram of resveratrol-βcd treatment; (B) Changes in body weight of the control group, negative control group (resveratrol-βcd alone), POI model group, and treatment group (POI + resveratrol-βcd) during the treatment, n = 5; (C) On the 20 day after treatment began, the ovaries of the mice were isolated and weighed (D) , with each point representing the weight of one ovary, n = 8; (E) Typical images of follicles at different stages in the ovaries, scale bar = 500 μm and the corresponding statistical analysis results (F) , n = 5; (G) Typical western blot result <t>of</t> <t>LHX8</t> and <t>NOBOX</t> expression levels in ovarian tissue, n = 3, see the other two western blot replicates in Supplementary Fig. ; All the repetitive results of western blot in this paper can be found in Supplementary Fig. , which will not be described afterwards; (H) Total RNA was extracted from ovarian tissue, and qPCR was used to analyze the transcriptional changes of Ddx4 and Pou5f1 , n = 5; (I) On day 20 post treatment, mouse serum was collected to detect AMH, FSH and E2 (J) levels in the blood, n = 5. (K) Estrous cycles examination by vaginal smears, scale bar = 200 μm, percentage of time on cycle phase was shown on the right, M/D = Metestrus and Diestrus, n = 10; (L) Reproductive activity analysis of different treatment group, n = 15; Statistical analysis was performed using two-way ANOVA (B) , and one-way ANOVA ( D,F,H,I,J and K ) comparison was made POI vs. control, POI vs. resveratrol-βcd and POI vs. POI + resveratrol-βcd; ns, not significant
    Anti Nobox Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti nobox antibody/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    anti nobox antibody - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    92
    Abcam nobox antibody
    Resveratrol-βcd can inhibit the progression of POI in a mouse model. (A) Schematic diagram of resveratrol-βcd treatment; (B) Changes in body weight of the control group, negative control group (resveratrol-βcd alone), POI model group, and treatment group (POI + resveratrol-βcd) during the treatment, n = 5; (C) On the 20 day after treatment began, the ovaries of the mice were isolated and weighed (D) , with each point representing the weight of one ovary, n = 8; (E) Typical images of follicles at different stages in the ovaries, scale bar = 500 μm and the corresponding statistical analysis results (F) , n = 5; (G) Typical western blot result <t>of</t> <t>LHX8</t> and <t>NOBOX</t> expression levels in ovarian tissue, n = 3, see the other two western blot replicates in Supplementary Fig. ; All the repetitive results of western blot in this paper can be found in Supplementary Fig. , which will not be described afterwards; (H) Total RNA was extracted from ovarian tissue, and qPCR was used to analyze the transcriptional changes of Ddx4 and Pou5f1 , n = 5; (I) On day 20 post treatment, mouse serum was collected to detect AMH, FSH and E2 (J) levels in the blood, n = 5. (K) Estrous cycles examination by vaginal smears, scale bar = 200 μm, percentage of time on cycle phase was shown on the right, M/D = Metestrus and Diestrus, n = 10; (L) Reproductive activity analysis of different treatment group, n = 15; Statistical analysis was performed using two-way ANOVA (B) , and one-way ANOVA ( D,F,H,I,J and K ) comparison was made POI vs. control, POI vs. resveratrol-βcd and POI vs. POI + resveratrol-βcd; ns, not significant
    Nobox Antibody, supplied by Abcam, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nobox antibody/product/Abcam
    Average 92 stars, based on 1 article reviews
    nobox antibody - by Bioz Stars, 2026-03
    92/100 stars
      Buy from Supplier

    Image Search Results


    Resveratrol-βcd can inhibit the progression of POI in a mouse model. (A) Schematic diagram of resveratrol-βcd treatment; (B) Changes in body weight of the control group, negative control group (resveratrol-βcd alone), POI model group, and treatment group (POI + resveratrol-βcd) during the treatment, n = 5; (C) On the 20 day after treatment began, the ovaries of the mice were isolated and weighed (D) , with each point representing the weight of one ovary, n = 8; (E) Typical images of follicles at different stages in the ovaries, scale bar = 500 μm and the corresponding statistical analysis results (F) , n = 5; (G) Typical western blot result of LHX8 and NOBOX expression levels in ovarian tissue, n = 3, see the other two western blot replicates in Supplementary Fig. ; All the repetitive results of western blot in this paper can be found in Supplementary Fig. , which will not be described afterwards; (H) Total RNA was extracted from ovarian tissue, and qPCR was used to analyze the transcriptional changes of Ddx4 and Pou5f1 , n = 5; (I) On day 20 post treatment, mouse serum was collected to detect AMH, FSH and E2 (J) levels in the blood, n = 5. (K) Estrous cycles examination by vaginal smears, scale bar = 200 μm, percentage of time on cycle phase was shown on the right, M/D = Metestrus and Diestrus, n = 10; (L) Reproductive activity analysis of different treatment group, n = 15; Statistical analysis was performed using two-way ANOVA (B) , and one-way ANOVA ( D,F,H,I,J and K ) comparison was made POI vs. control, POI vs. resveratrol-βcd and POI vs. POI + resveratrol-βcd; ns, not significant

    Journal: Journal of Ovarian Research

    Article Title: Resveratrol-βcd inhibited premature ovarian insufficiency progression by regulating granulosa cell autophagy

    doi: 10.1186/s13048-024-01344-0

    Figure Lengend Snippet: Resveratrol-βcd can inhibit the progression of POI in a mouse model. (A) Schematic diagram of resveratrol-βcd treatment; (B) Changes in body weight of the control group, negative control group (resveratrol-βcd alone), POI model group, and treatment group (POI + resveratrol-βcd) during the treatment, n = 5; (C) On the 20 day after treatment began, the ovaries of the mice were isolated and weighed (D) , with each point representing the weight of one ovary, n = 8; (E) Typical images of follicles at different stages in the ovaries, scale bar = 500 μm and the corresponding statistical analysis results (F) , n = 5; (G) Typical western blot result of LHX8 and NOBOX expression levels in ovarian tissue, n = 3, see the other two western blot replicates in Supplementary Fig. ; All the repetitive results of western blot in this paper can be found in Supplementary Fig. , which will not be described afterwards; (H) Total RNA was extracted from ovarian tissue, and qPCR was used to analyze the transcriptional changes of Ddx4 and Pou5f1 , n = 5; (I) On day 20 post treatment, mouse serum was collected to detect AMH, FSH and E2 (J) levels in the blood, n = 5. (K) Estrous cycles examination by vaginal smears, scale bar = 200 μm, percentage of time on cycle phase was shown on the right, M/D = Metestrus and Diestrus, n = 10; (L) Reproductive activity analysis of different treatment group, n = 15; Statistical analysis was performed using two-way ANOVA (B) , and one-way ANOVA ( D,F,H,I,J and K ) comparison was made POI vs. control, POI vs. resveratrol-βcd and POI vs. POI + resveratrol-βcd; ns, not significant

    Article Snippet: The primary antibodies used in this experiment included LHX8 (Sigma, SAB2101342), NOBOX (Sigma, SAB2105362), SQSTM1 (CST, #88,588), LC3I/II (LC3A/B CST, #12,741), β-actin (Proteintech, 20536-1-AP), JAK2 (CST, #3230), and p-JAK2 (CST, #3771).

    Techniques: Negative Control, Isolation, Western Blot, Expressing, Activity Assay, Comparison